ReviewOncotarget2017
Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies.
Yuanyuan Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papercites it
ReviewOncotarget2017
Yuanyuan Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.